Analyst consensus rating
Zimmer Biomet Holdings Analyst Rating: none
Direct answer
Zimmer Biomet Holdings's consensus rating is none.
21 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $107.57.
Forecast evidence checked September 9, 2026.
Get free Zimmer Biomet Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $94.22
- Average price target
- $107.57
- High price target
- $130.00
- Low price target
- $93.00
- Low target gap
- -1.3%
- Target upside
- +14.2%
- High target gap
- +38%
- Target range width
- 39.3%
- Consensus rating
- none
- Analysts
- 21
- Evidence date
- September 9, 2026
- Valid through
- September 16, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Zimmer Biomet Holdings?
Zimmer Biomet Holdings has a verified none consensus. The same dataset has an average price target of $107.57.
How far are Zimmer Biomet Holdings's low and high targets from the recorded price?
The low target implies -1.3%, while the high target implies +38%.
How many analysts are included in Zimmer Biomet Holdings's consensus?
The verified consensus includes 21 analysts.
How is Zimmer Biomet Holdings's target upside or downside calculated?
The average target of $107.57 is divided by the recorded price of $94.22, then one is subtracted to produce +14.2%. This does not guarantee a future return.
When was Zimmer Biomet Holdings's analyst forecast verified?
The data was verified on 2026-09-09. The dataset is valid through 2026-09-16.